<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Translocation t(11;17) is a well-recognized variant of <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> (APL) and has also been identified in patients with mixed-lineage <z:hpo ids='HP_0001909'>leukemia</z:hpo> (MLL) non-APL <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we describe two patients bearing translocation t(11;17) presenting with a clinical diagnosis of de novo <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>): the first with sole karyotypic abnormality 46,XY,t(11;17)(p11.2; p13) and the second where it represented one of the two karyotypic abnormalities 46,XX,del(5)(q13q33)46,XX,del(5)(q13q33),t(11;17)(q24;q23) </plain></SENT>
<SENT sid="2" pm="."><plain>Molecular characterization of both cases failed to identify fusion transcripts involving MLL or PLZF-RARA and no collaborating <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> commonly found among <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients were seen in either case, suggesting the presence of an as yet unidentified oncogenic fusion protein </plain></SENT>
</text></document>